Literature DB >> 28994902

Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women.

Debra L Bogen1,2,3, Barbara H Hanusa2, James M Perel3, Frederick Sherman4, Marla A Mendelson5, Katherine L Wisner6.   

Abstract

BACKGROUND: Methadone is a standard treatment for opioid dependence in pregnancy; however, its impact on maternal corrected QT interval (QTc) has not been evaluated. We studied the association between methadone dose and enantiomer-specific plasma concentrations and QTc among pregnant and postpartum women and newborns. We assessed the relevance of QTc screening guidelines for pregnant women and infants.
METHODS: From 2006 to 2008, plasma methadone concentrations were measured during pregnancy, postpartum, and in cord blood in women treated for opioid dependence at a single treatment program. Electrocardiograms (ECGs) were obtained at peak methadone concentrations in mothers and within 48 hours of birth for infants. Pearson correlations were performed at each time point for QTc and R-methadone, S-methadone, and total methadone concentrations and ratio of R-methadone/S-methadone concentrations.
RESULTS: Mean (SD) daily methadone dose for the 25 women was 94.2 (39.1) mg during pregnancy and 112.5 (46.6) mg postpartum. During the third trimester, higher methadone dose and R-methadone concentration correlated with longer QTc (Pearson r = 0.67, P < .001 and Pearson r = 0.49, P = .02, respectively), while S-methadone concentration, R-methadone/S-methadone concentration ratio, and total methadone concentration did not. Postpartum, QTc did not significantly correlate with dose or enantiomer concentrations. Infant QTc did not correlate with maternal dose at delivery or enantiomer-specific cord methadone concentrations. In pregnant and postpartum women, 13% and 17%, respectively, had QTc ≥ 450 ms, as did 19% of infants.
CONCLUSIONS: QTc correlated with dose and R-methadone concentration during the third trimester. However, longer QTc was common among women during and after pregnancy. Given the relatively high rate of QTc > 450 ms, an ECG before and after methadone initiation is advisable for pregnant and postpartum women. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28994902      PMCID: PMC7044002          DOI: 10.4088/JCP.16m11318

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  37 in total

Review 1.  Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline.

Authors:  Roger Chou; Melissa B Weimer; Tracy Dana
Journal:  J Pain       Date:  2014-04       Impact factor: 5.820

Review 2.  A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors:  R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal:  Expert Rev Clin Pharmacol       Date:  2013-05       Impact factor: 5.045

3.  Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

Authors:  Debra L Bogen; James M Perel; Joseph C Helsel; Barbara H Hanusa; Matthew Thompson; Katherine L Wisner
Journal:  Breastfeed Med       Date:  2011-02-24       Impact factor: 1.817

4.  Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

Authors:  M Nosè; I Bighelli; M Castellazzi; G Martinotti; G Carrà; C Lucii; G Ostuzzi; F Sozzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-15       Impact factor: 6.892

5.  Maternal methadone may cause arrhythmias in neonates.

Authors:  Tarique Hussain; Andrew K Ewer
Journal:  Acta Paediatr       Date:  2007-03-21       Impact factor: 2.299

6.  Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing.

Authors:  E J Begg; T J Malpas; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

7.  Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.

Authors:  Gabrielle K Welle-Strand; Svetlana Skurtveit; Lauren M Jansson; Brittelise Bakstad; Lisa Bjarkø; Edle Ravndal
Journal:  Acta Paediatr       Date:  2013-09-02       Impact factor: 2.299

8.  The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.

Authors:  Elisha M Wachman; P K Newby; Joy Vreeland; John Byun; Anthony Bonzagni; Howard Bauchner; Barbara L Philipp
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

9.  Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

Authors:  D J Foster; A A Somogyi; K R Dyer; J M White; F Bochner
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

10.  Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.

Authors:  Chantal Csajka; Séverine Crettol; Monia Guidi; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2016-12       Impact factor: 6.447

View more
  3 in total

Review 1.  Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy.

Authors:  P Kaitlyn Edelson; Sarah N Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-22

2.  Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models.

Authors:  Xuerong Wen; Shuang Wang; Adam K Lewkowitz; Kristina E Ward; Erin Christine Brousseau; Kimford J Meador
Journal:  Drug Saf       Date:  2021-10-05       Impact factor: 5.606

3.  Prevalence and Risk Factors of QTc Prolongation During Pregnancy.

Authors:  Chaodi Luo; Zhenzhen Duan; Yi Jiang; Peng Liu; Yang Yan; Dan Han
Journal:  Front Cardiovasc Med       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.